UK regulator approves use of Pfizer/BioNTech vaccine in 5 to 11-year olds

A new paediatric formulation of the Pfizer BioNTech COVID-19 vaccine has been approved for children aged 5 to 11 after meeting the required safety, quality and effectiveness standards.